| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.15▲ | 27.97▲ | 27.97▲ | 27.44▲ | 29.57▼ |
| MA10 | 28.00▲ | 27.83▲ | 27.72▲ | 27.70▲ | 29.97▼ |
| MA20 | 27.77▲ | 27.80▲ | 27.70▲ | 29.58▼ | 33.08▼ |
| MA50 | 27.67▲ | 27.42▲ | 27.67▲ | 30.58▼ | 31.17▼ |
| MA100 | 27.54▲ | 28.45▼ | 29.41▼ | 33.35▼ | 27.38▲ |
| MA200 | 29.03▼ | 30.11▼ | 30.37▼ | 32.52▼ | 24.11▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.042▲ | 0.045▲ | 0.082▲ | -0.156▼ | -0.758▼ |
| RSI | 57.142▲ | 57.643▲ | 56.459▲ | 42.720▼ | 41.305▼ |
| STOCH | 90.492▲ | 86.343▲ | 77.547 | 36.921 | 36.725 |
| WILL %R | -1.389▲ | -0.893▲ | -22.378▲ | -63.659 | -75.918▼ |
| CCI | 72.924 | 115.577▲ | 87.365 | -39.367 | -153.547▼ |
|
Wednesday, April 29, 2026 06:18 PM
Achieved Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back PainActivity Report for Quarter Ended March 31, 2026 (Appendix ...
|
|
Wednesday, April 29, 2026 02:00 AM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase ...
|
|
Tuesday, April 28, 2026 06:07 PM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 27.44 | 28.19 | 27.3407 | 28.06 | 35,290 |
| 30/04/26 | 26.8501 | 27.86 | 26.8501 | 27.79 | 20,937 |
| 29/04/26 | 28.08 | 28.08 | 26.35 | 26.68 | 35,285 |
| 28/04/26 | 26.43 | 28.55 | 26.43 | 27.93 | 46,358 |
| 27/04/26 | 26.95 | 27.70 | 26.27 | 26.75 | 51,979 |
| 24/04/26 | 28.2693 | 28.2693 | 26.28 | 27.03 | 55,948 |
| 23/04/26 | 28.75 | 28.77 | 25.24 | 27.56 | 94,926 |
| 22/04/26 | 28.09 | 29.275 | 28.09 | 28.64 | 37,497 |
| 21/04/26 | 28.45 | 29.25 | 27.50 | 28.09 | 32,628 |
| 20/04/26 | 30.00 | 30.505 | 27.02 | 28.45 | 71,815 |
|
|
||||
|
|
||||
|
|